Literature DB >> 9257829

Mechanisms of L-selectin regulation by activated T cells.

C C Chao1, R Jensen, M O Dailey.   

Abstract

The activation of T cells through the TCR results in the differential regulation of a set of adhesion molecules that dramatically alters lymphocyte migration and tissue localization properties in vivo. L-selectin, the lymph node homing receptor, is central to the control of lymphocyte recirculation. We examined the regulation of L-selectin as a function of time after activation in vitro. Within an hour of stimulation, T cells down regulate L-selectin, with a 90% loss by 4 h, due to accelerated proteolytic cleavage. Over the course of the following 48 h, surface receptor expression increases markedly. This is due to an increase in L-selectin mRNA, which, in turn, results from increased message stability. During the next several days after activation, L-selectin levels decrease, resulting in L-selectin-negative T cells by 5 to 7 days after stimulation. This decrease occurs faster in CD8 than in CD4 T cells. During this phase of regulation, L-selectin message remains stable even as the level of specific mRNA continuously decreases. This indicates that the L-selectin-negative phenotype of T cells late after activation is due to the down-regulation of gene transcription. These results demonstrate that after stimulation through the TCR, the expression of L-selectin changes in a triphasic pattern, with an initial marked decrease, followed by a transient phase of superinduction and then a loss of expression. These changes are regulated through the complex interactions between several mechanisms at the transcriptional, post-transcriptional, and protein turnover levels.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9257829

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  52 in total

1.  Molecular profiling of cytomegalovirus-induced human CD8+ T cell differentiation.

Authors:  Kirsten M L Hertoghs; Perry D Moerland; Amber van Stijn; Ester B M Remmerswaal; Sila L Yong; Pablo J E J van de Berg; S Marieke van Ham; Frank Baas; Ineke J M ten Berge; René A W van Lier
Journal:  J Clin Invest       Date:  2010-11       Impact factor: 14.808

2.  Impairment of leukocyte trafficking in a murine pleuritis model by IL-4 and IL-10.

Authors:  Jay S Fine; Alberto Rojas-Triana; James V Jackson; Laura W Engstrom; Gregory S Deno; Daniel J Lundell; Loretta A Bober
Journal:  Inflammation       Date:  2003-08       Impact factor: 4.092

3.  Biochemical and functional characterization of three activated macrophage populations.

Authors:  Justin P Edwards; Xia Zhang; Kenneth A Frauwirth; David M Mosser
Journal:  J Leukoc Biol       Date:  2006-08-11       Impact factor: 4.962

4.  Differentiation of CD8+ T cells into effector cells is enhanced by physiological range hyperthermia.

Authors:  Thomas A Mace; Lingwen Zhong; Casey Kilpatrick; Evan Zynda; Chen-Ting Lee; Maegan Capitano; Hans Minderman; Elizabeth A Repasky
Journal:  J Leukoc Biol       Date:  2011-08-26       Impact factor: 4.962

5.  Profound blockade of T cell activation requires concomitant inhibition of different class I PI3K isoforms.

Authors:  Belén Blanco; M Carmen Herrero-Sánchez; Concepción Rodríguez-Serrano; Mercedes Sánchez-Barba; M Consuelo Del Cañizo
Journal:  Immunol Res       Date:  2015-06       Impact factor: 2.829

6.  A CD40 targeting peptide prevents severe symptoms in experimental autoimmune encephalomyelitis.

Authors:  Gisela M Vaitaitis; Martin G Yussman; David H Wagner
Journal:  J Neuroimmunol       Date:  2019-03-21       Impact factor: 3.478

7.  CD11a regulates effector CD8 T cell differentiation and central memory development in response to infection with Listeria monocytogenes.

Authors:  Tina O Bose; Quynh-Mai Pham; Evan R Jellison; Juliette Mouries; Christie M Ballantyne; Leo Lefrançois
Journal:  Infect Immun       Date:  2013-01-28       Impact factor: 3.441

8.  Early effector cells survive the contraction phase in malaria infection and generate both central and effector memory T cells.

Authors:  Michael M Opata; Victor H Carpio; Samad A Ibitokou; Brian E Dillon; Joshua M Obiero; Robin Stephens
Journal:  J Immunol       Date:  2015-04-24       Impact factor: 5.422

9.  Cellular immune responses associated with occult hepatitis C virus infection of the liver.

Authors:  Juan A Quiroga; Silvia Llorente; Inmaculada Castillo; Elena Rodríguez-Iñigo; Margarita Pardo; Vicente Carreño
Journal:  J Virol       Date:  2006-11       Impact factor: 5.103

10.  An Slfn2 mutation causes lymphoid and myeloid immunodeficiency due to loss of immune cell quiescence.

Authors:  Michael Berger; Philippe Krebs; Karine Crozat; Xiaohong Li; Ben A Croker; Owen M Siggs; Daniel Popkin; Xin Du; Brian R Lawson; Argyrios N Theofilopoulos; Yu Xia; Kevin Khovananth; Eva Marie Moresco; Takashi Satoh; Osamu Takeuchi; Shizuo Akira; Bruce Beutler
Journal:  Nat Immunol       Date:  2010-02-28       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.